ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수면제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 259억 2,000만 달러에서 2026년에는 280억 6,000만 달러에 이르고, CAGR 8.2%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 첨단 수면제의 접근성 어려움, 불면증 환자 증가, 처방전 기반 수면제 의존성, 병원 기반 수면장애 치료 증가, 주요 치료제로서 벤조디아제핀의 등장 등을 꼽을 수 있습니다.
수면제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 380억 5,000만 달러에 이르고, CAGR은 7.9%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 올레신 수용체 길항제 개발, 멜라토닌 수용체 작용제 사용 증가, 시판 수면 보조제의 성장, 재택치료 및 전문 수면 센터의 확대, 원격 의료 및 온라인 약국 이용 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 전 세계 수면장애 유병률 증가, 비벤조디아제핀계 최면제 사용 증가, 허브 및 건강기능식품형 수면 보조제의 성장, 온라인 약국 유통 채널 확대, 수면 건강 및 웰빙에 대한 인식 증가 등이 있습니다.
향후 몇 년 동안 정신질환의 유병률 증가가 수면제 시장의 성장을 견인할 것으로 예측됩니다. 정신질환은 개인의 기분, 사고 과정, 행동, 그리고 일상 생활 전반에 영향을 미치는 광범위한 정신 건강 상태를 말합니다. 정신질환 증가는 만성적인 스트레스 증가와 밀접한 관련이 있습니다. 장기간의 스트레스는 정상적인 뇌 기능을 방해하고 정신질환의 발병과 악화를 초래할 수 있기 때문입니다. 수면제는 많은 정신질환에서 자주 손상되는 수면의 질을 개선함으로써 정신질환을 앓고 있는 사람들을 돕습니다. 이러한 약물은 수면과 각성 주기를 조절하고 불면증과 불안과 같은 증상을 완화하여 전반적인 정신 건강과 일상 업무 수행 능력을 향상시키는 데 도움을 줍니다. 예를 들어, 전미정신질환연맹(NAMI)과 NextStep Solutions Behavioral Health의 보고서에 따르면, 2025년 기준 미국 보건당국은 2023년 중증 정신질환(SMI) 유병률이 약 5.44%였으며, 2024년에도 성인의 약 5.6%로 거의 비슷한 수준을 유지하고 있으며, 이 심각한 범주 내에서는 비교적 안정적임을 보여주고 있습니다. 따라서 정신질환의 유병률 증가는 수면제 시장의 성장에 기여하고 있습니다.
수면제 시장에서 활동하는 주요 기업들은 치료 포트폴리오를 확장하고 고급 수면장애 솔루션에 대한 수요 증가에 대응하기 위해 중등도에서 중증의 폐쇄성 수면무호흡증(OSA) 치료제를 포함한 혁신적인 제품 개발에 주력하고 있습니다. 중등도에서 중증의 폐쇄성 수면무호흡증은 수면 중 반복적인 기도 폐쇄를 특징으로 하는 심각한 수면장애로, 잦은 호흡 정지, 현저한 산소 수준 저하, 수면의 질 저하를 유발합니다. 예를 들어, 2024년 12월 미국 제약회사 일라이 릴리(Eli Lilly & Co.)는 미국 식품의약국(FDA)으로부터 중등도에서 중증의 폐쇄성 수면무호흡증(OSA) 및 비만을 동반한 성인 환자를 위한 최초의 처방 가능한 치료제로서 제프바운드(tirzepatide)가 승인 받았다고 발표했습니다. 제프바운드는 칼로리 제한 및 신체 활동량 증가와 병용하는 것을 전제로 OSA 치료 결과를 개선할 수 있는 새로운 약리학적 옵션을 제공합니다. 이번 승인은 수면의 질, 주간 활동 능력 및 전반적인 건강에 중대한 영향을 미치지만 그 중요성이 과소평가되는 경우가 많은 OSA 치료에 대한 임상적 요구가 증가하고 있음을 보여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Sleep medication refers to pharmaceutical agents developed to help individuals fall asleep more quickly, maintain sleep for longer periods, or enhance overall sleep quality. The main objective of sleep medication is to manage sleep disorders, such as insomnia, by regulating the body's sleep-wake cycle.
The main types of sleep medication include prescription-based drugs and over-the-counter (OTC) drugs. Prescription-based drugs are medications that require a physician's prescription due to their strength, potential side effects, or the need for clinical supervision. Sleep medications are used to treat various sleep disorders, including insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking, and others. They are classified into categories such as benzodiazepines, antidepressants, antihistamines, sedating antipsychotics, and other drug classes. These medications are distributed through hospital pharmacies, online pharmacies, and retail pharmacies, and are used by key end users such as hospitals, homecare settings, specialty centers, and others.
Tariffs have affected the sleep medication market by increasing costs for imported active pharmaceutical ingredients (APIs) and formulation chemicals, impacting prescription-based drugs and OTC supplements. Segments such as benzodiazepines and melatonin receptor agonists are particularly affected, with Asia-Pacific regions like China and India experiencing higher import duties. This has led to increased production costs and pricing adjustments. On the positive side, tariffs are encouraging local manufacturing of sleep medications, promoting domestic pharmaceutical innovation, and improving supply chain resilience.
The sleep medication market research report is one of a series of new reports from The Business Research Company that provides sleep medication market statistics, including sleep medication industry global market size, regional shares, competitors with a sleep medication market share, detailed sleep medication market segments, market trends and opportunities, and any further data you may need to thrive in the sleep medication industry. This sleep medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sleep medication market size has grown strongly in recent years. It will grow from $25.92 billion in 2025 to $28.06 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to limited availability of advanced sleep medications, growing insomnia cases, reliance on prescription-based sleep drugs, increasing hospital-based sleep disorder treatments, emergence of benzodiazepines as primary therapy.
The sleep medication market size is expected to see strong growth in the next few years. It will grow to $38.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to development of orexin receptor antagonists, rising use of melatonin receptor agonists, growth in otc sleep supplements, expansion of homecare and speciality sleep centres, increasing telemedicine and online pharmacy adoption. Major trends in the forecast period include rising prevalence of sleep disorders globally, increased adoption of non-benzodiazepine hypnotics, growth in herbal and dietary sleep supplements, expansion of online pharmacy distribution channels, rising awareness about sleep health and wellness.
The rising prevalence of mental illness is anticipated to drive the growth of the sleep medication market in the coming years. Mental illness encompasses a broad range of mental health conditions that influence an individual's mood, thought processes, behavior, and overall daily functioning. The increasing occurrence of mental illness is largely linked to escalating levels of chronic stress, as prolonged stress can disrupt normal brain function and either trigger or exacerbate mental health disorders. Sleep medications support individuals with mental illness by improving sleep quality, which is frequently impaired in many mental health conditions. These medications help regulate the sleep-wake cycle, alleviate symptoms such as insomnia and anxiety, and thereby enhance overall mental well-being and daily performance. For example, in 2025, according to the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies reported that the prevalence of serious mental illness (SMI) was approximately 5.44% in 2023 and remained similar in 2024 at around 5.6% of adults, indicating relative stability within this severe category. Therefore, the increasing prevalence of mental illness is contributing to the growth of the sleep medication market.
Major companies operating in the sleep medication market are concentrating on the development of innovative products, including treatments for moderate-to-severe obstructive sleep apnea, to broaden their therapeutic portfolios and address the growing demand for advanced sleep disorder solutions. Moderate-to-severe obstructive sleep apnea is a serious sleep condition characterized by repeated airway obstructions during sleep, leading to frequent interruptions in breathing, significantly reduced oxygen levels, and disrupted sleep quality. For instance, in December 2024, Eli Lilly and Company, a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration approved Zepbound (tirzepatide) as the first prescription therapy specifically indicated for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Intended for use alongside calorie reduction and increased physical activity, Zepbound introduces a new pharmacological option for improving OSA outcomes. This approval underscores the growing clinical need for effective OSA treatments, a condition that is often underestimated despite its substantial impact on sleep quality, daytime functioning, and overall health.
In July 2024, Cosette Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Ambien (zolpidem tartrate), a fast-acting sleep medication, and Ambien CR tablets (6.25 mg once daily immediately before bedtime) from Sanofi S.A. for an undisclosed amount. Through this acquisition, Cosette Pharmaceuticals significantly strengthened its presence in the U.S. sleep medicine market by adding well-established insomnia treatments to its product portfolio. Sanofi S.A. is a France-based pharmaceutical company engaged in the development of sleep medications.
Major companies operating in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC
North America was the largest region in the sleep medication market in 2025. The regions covered in the sleep medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sleep medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sleep medication market consists of sales of hormonal sleep aids, anticonvulsants, cannabinoids, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sleep Medication Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sleep medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sleep medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleep medication market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Prescription-Based Drugs; Over-The-Counter (OTC) Drugs
2) By Sleep Disorder Type: Insomnia; Sleep Apnea; Restless Legs Syndrome; Narcolepsy; Sleep Walking; Other Sleep Disorders
3) By Drug Class: Benzodiazepines; Antidepressants; Antihistamines; Sedating Antipsychotics; Other Drug Classes
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Speciality Centres; Other End-Users
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Prevalence Of Sleep Disorders Globally
4.2.2 Increased Adoption Of Non-Benzodiazepine Hypnotics
4.2.3 Growth In Herbal And Dietary Sleep Supplements
4.2.4 Expansion Of Online Pharmacy Distribution Channels
4.2.5 Rising Awareness About Sleep Health And Wellness
5. Sleep Medication Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Homecare
5.3 Speciality Centres
5.4 Pharmacies
5.5 Sleep Clinics
6. Sleep Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Sleep Medication Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Sleep Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Sleep Medication Market Size, Comparisons And Growth Rate Analysis
7.3. Global Sleep Medication Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Sleep Medication Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Sleep Medication Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Sleep Medication Market Segmentation
9.1. Global Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Sleep Medication Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Speciality Centres, Other End-Users
9.6. Global Sleep Medication Market, Sub-Segmentation Of Prescription-Based Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Sleep Medication Market, Sub-Segmentation Of Over-The-Counter (OTC) Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Sleep Medication Market
12.1. China Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Sleep Medication Market
13.1. India Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Sleep Medication Market
14.1. Japan Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Sleep Medication Market
15.1. Australia Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Sleep Medication Market
16.1. Indonesia Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Sleep Medication Market
17.1. South Korea Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Sleep Medication Market
18.1. Taiwan Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Sleep Medication Market
19.1. South East Asia Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Sleep Medication Market
20.1. Western Europe Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Sleep Medication Market
21.1. UK Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Sleep Medication Market
22.1. Germany Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Sleep Medication Market
23.1. France Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Sleep Medication Market
24.1. Italy Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Sleep Medication Market
25.1. Spain Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Sleep Medication Market
26.1. Eastern Europe Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Sleep Medication Market
27.1. Russia Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Sleep Medication Market
28.1. North America Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Sleep Medication Market
29.1. USA Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Sleep Medication Market
30.1. Canada Sleep Medication Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Sleep Medication Market
31.1. South America Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Sleep Medication Market
32.1. Brazil Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Sleep Medication Market
33.1. Middle East Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Sleep Medication Market
34.1. Africa Sleep Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Sleep Medication Market, Segmentation By Type, Segmentation By Sleep Disorder Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Sleep Medication Market Regulatory and Investment Landscape
36. Sleep Medication Market Competitive Landscape And Company Profiles
36.1. Sleep Medication Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Sleep Medication Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Sleep Medication Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
37. Sleep Medication Market Other Major And Innovative Companies
Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC
38. Global Sleep Medication Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Sleep Medication Market
40. Sleep Medication Market High Potential Countries, Segments and Strategies
40.1 Sleep Medication Market In 2030 - Countries Offering Most New Opportunities
40.2 Sleep Medication Market In 2030 - Segments Offering Most New Opportunities
40.3 Sleep Medication Market In 2030 - Growth Strategies
